Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis 2020-09, Vol.26 (10), p.1268-1269
Hauptverfasser:	Carandini, Tiziana, Pietroboni, Anna Margherita, Sacchi, Luca, De Riz, Milena Alessandra, Pozzato, Mattia, Arighi, Andrea, Fumagalli, Giorgio Giulio, Martinelli Boneschi, Filippo, Galimberti, Daniela, Scarpini, Elio
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Alemtuzumab - adverse effects Coronavirus Infections - complications Coronavirus Infections - immunology Coronavirus Infections - physiopathology COVID-19 Female Humans Immunosuppression Immunosuppressive Agents - adverse effects Immunotherapy Leukopenia - chemically induced Leukopenia - immunology Lymphopenia - chemically induced Lymphopenia - immunology Monoclonal antibodies Multiple sclerosis Multiple Sclerosis, Relapsing-Remitting - complications Multiple Sclerosis, Relapsing-Remitting - drug therapy Neutropenia - chemically induced Neutropenia - immunology Pandemics Pneumonia, Viral - complications Pneumonia, Viral - immunology Pneumonia, Viral - physiopathology Severity of Illness Index
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!